[Glucose-independent impact of the glitazones on the cardiovascular outcome].

Hanefeld, M

[Glucose-independent impact of the glitazones on the cardiovascular outcome]. [electronic resource] - MMW Fortschritte der Medizin Jan 2005 - 37-9 p. digital

Publication Type: Comparative Study; Journal Article; Review

1438-3276


Body Mass Index
Cardiovascular Diseases--etiology
Diabetes Mellitus, Type 2--complications
Double-Blind Method
Drug Therapy, Combination
Humans
Hypoglycemic Agents--administration & dosage
Insulin Resistance
Longitudinal Studies
Middle Aged
Obesity--complications
Pioglitazone
Primary Prevention
Prospective Studies
Randomized Controlled Trials as Topic
Risk Factors
Rosiglitazone
Thiazolidinediones--administration & dosage